The approval of the combination of olanzapine and fluoxetine for treating bipolar depression marks the first time a drug therapy has been indicated for the most difficult to treat phase of the disorder.Mechcatie, Elizabeth
Become a Study.com member to unlock this answer!Create your account View this answer Zyprexa is an antipsychotic drug that is usually used to treat schizophrenia. Its generic name is Olanzapine. It can also be used to treat bipolar... ...
The PDA accesses Medicaid's preferred drug list, patient-specific prescription histories, and drug interaction screening tools. Medicaid lends a hand The Texas Medicaid agency announced that it will not include the atypical antipsychotic Zyprexa (olanzapine) on its preferred drug list. To prescribe Zyp...
Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia. Neuropsychopharmacology. 2010;35(4):904–12. doi:10.1038/npp.2009.192. 131. Lui S, Li T, Deng W, Jiang L, Wu Q, Tang H, et al. Short-term effects of antipsychotic treatment...
The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine This multicenter, open-label study was designed to assess the efficacy and tolerability of olanzapine in patients with chronic schizophrenia who are resist... D Mrk,JN...
Fluoxetine is a pharmaceutical drug known for its antidepressant qualities. The name “fluoxetine” is something of a generic term used to describe the ingredient combination, and medications aren’t usually sold under this name but rather under brand names that reflect different manufacturers’ takes...
The first 7 months represent the obligate period for drug treatment, during which subjects were treated and any subjects developing dementia were eliminated from the analysis. (A) Atorvastatin; (B) lovastatin; (C) simvastatin; (D) summary of hazard ratios for each of the statins using model 3...
Unless specifically directed otherwise, a pharmacist will fill a prescription for this medication with the generic version of the drug, rather than a branded one, because generics are much less expensive. This drug is designed to change the chemistry of the brain to help patients with conditions ...
research investment based companies in the coming years. The competition from generics will put additional burden in the coming years. Further, economic slowdown in the European region will cut down healthcare cost under austerity measures and generic products are likely to move on with greater ...
Lipkovich I, Deberdt W, Csernansky JG, Buckley P, Peuskens J, Kollack-Walker S, Zhang Y, Liu-Seifert H, Houston JP: Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy. J Psychiatr Res. 2007, 41: 305-310. 10.1016/j...